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Sleep Interrupted: Nocturnal Care Disturbances
Eileen Danaher Hacker, Purvi Patel, Megan Stainthorpe.
University of Illinois at Chicago
Purpose: The importance of sleep in the hospital envi-
ronment is often overshadowed by other competing needs.
Care requirements during hours generally reserved for
sleep result in nocturnal disruptions that impact sleep
quality. Patients receiving high dose chemotherapy fol-
lowed by hematopoietic stem cell transplantation (HSCT)
typically require an extended hospitalization. This inten-
sive cancer treatment places patients at risk for frequent
sleep interruptions due to nocturnal care requirements.
The types and frequency of night-time care requirements
in HSCT patients have not been documented making it
difﬁcult to determine which interactions are modiﬁable.
The purpose of this study is to (1) examine the types and
frequency of HSCT patient/healthcare provider interactions
occurring between 9:00 pm and 7:00 am; and, (2) deter-
mine the frequency of sleep disturbance recognition by
healthcare providers in hospitalized stem cell transplant
patients.
Methods: This retrospective study examined hourly
nocturnal care interactions over a four-night period using
the electronic medical record. The data was extracted from
hospitalized HSCT patients (n ¼ 40) during the acute
post recovery period. Data for each HSCT patient was
retrieved on days four through eight when patients were
experiencing the toxic effects of the intensive cancer
therapy.
Results: A total of 1643 nocturnal care interactions occurred
over 160 nights (range, 20 e 58 interactions per patient over
four nights). Interactions were clustered between the hours
of 12:00 e 1:00 am and 4:00 e 5:00 am, accounting for 26%
and 25% of interactions, respectively. The majority involved
medication administration (39.9%) followed by vital sign
assessment (20.9%), obtaining blood samples (11%), intrave-
nous catheter maintenance (9.9%), and patient assessments
independent of other listed activities (6.2%). Registered
nurses recorded patient-reported sleep disturbances for 29
subjects (72.5%) while physicians recorded sleep problems
for only 11 subjects (22.5%).
Conclusion: This study suggests that HSCT patients experi-
ence frequent sleep interruptions due to nocturnal care
requirements. Half of the interactions occurred between two
speciﬁc time periods. The other half occurred throughout the
night leaving patients with little time for uninterrupted
sleep. This study provides information to begin developing
care processes that minimize interactions at night and
maximize the time-intervals without interruptions.532
The Impact of Exercise On Hematopoietic Stem Cell
Transplant Patients
Randi Hoffmann. Mayo Clinic, Rochester, MN
The Impact of Exercise on Hematopoietic Stem Cell Trans-
plant Patients Background: Preliminary research in exercise
with patients undergoing hematopoietic stem cell trans-
plantation shows similar positive beneﬁts in physicalperformance and fatigue to research in cancer and physical
activity. Small sample sizes, lack of randomization and
heterogeneity of settings limit translation in to clinical
practice.
Objective: The aims of this study were to 1) test the feasi-
bility (recruitment, adherence and attrition) of introducing
an exercise intervention versus attention control with
patients undergoing a hematopoietic stem cell transplant
and 2) examine the relationship between the exercise
intervention versus the attention control on functional
capacity, fatigue, perceived exertion, muscular strength,
cardio-pulmonary status A third, exploratory aim was to
examine the relationships of attitudes, intention to exercise,
subjective norms and perceived behavioral control and
exercise behavior. (Based on The Theory of Planned Behavior,
Ajzen, 1992)
Methods: Sixty participants were randomly assigned to
either the exercise intervention or the attention control
group. Groups met three times per week for one hour.
Participants were followed during the stem cell collection (if
applicable), chemotherapy and recovery of their white count,
typically for six weeks. Outcomes included functional
performance (Functional Performance Inventory), fatigue
(Schwartz Cancer Fatigue Scale), cardio-pulmonary status
(Six Minute Walk) and muscular strength (grip strength test
and step ascent test).
Results: Compared to the attention control group, the
intervention group showed a statistically signiﬁcant differ-
ence on functional performance (P¼ .041), fatigue (P¼ .041),
cardiovascular and pulmonary status (P¼ .001) and one
measure of muscular strength (P < .001). Intention to exer-
cise and perceived behavioral control explained 20% and 25%
of the variance in exercise behavior (respectively).
Conclusions: This pilot study provides support that an
exercise program during transplant can improve function,
cardiopulmonary status and fatigue. Intention to exercise
and a belief that an exercise program is under their control
contributes to exercise adherence.
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A Randomized Study to Compare the Effect of 2-Hour and
6-Hour Schedules of Cryotherapy On the Incidence of
Severe Mucositis in High Dose Melphalan
Misty Lamprecht 1, Karen Tackett Rn 2, Joanne Lester 2. 1 Bone
Marrow Transplant, Ohio State University - James Cancer
Hospital, Mechanicsburg, OH; 2 Ohio State University - James
Cancer Hospital
Objectives: The primary objective is to measure the
maximum inpatient mucositis grade after 2- vs. 6-hours
standardized cryotherapy regimens in patients withmultiple
myeloma undergoing autologous hematopoietic stem cell
transplantation(HSCT). Secondary objectives include:
comparison of neutropenic fever and bacteremia incidence
after 2- vs. 6-hour cryotherapy regimens, and comparison of
patient-reported symptoms experienced with cryotherapy
after 2- vs 6-hour cryotherapy regimens.
Background: High dose Melphalan, a chemotherapy known
to cause mucositis in up to 40% of patients receiving it, is
used as the preparative regimen for patients with multiple
myeloma receiving autologous HSCT. The Oncology Nursing
Society Putting Evidence into Practice resource categorizes
use of cryotherapy for patients receiving bolus dose
Melphalan as “likely to be effective” in reducing mucositis.
Evidence supporting this included a randomized clinical trial
